Trump’s Opioid Commission Reveals Initial Findings, Ignores Marijuana

President Trump’s Commission on Combating Drug Addiction and the Opioid Crisis was due to submit their initial report on June 27, but committee chair Chris Christie requested multiple delays to ensure the onslaught of public input was properly analyzed.

“We said we need time to go through this, and the president’s senior staff agreed,” Christie said of the delays.

This afternoon, Christie and the rest of the Commission held a public teleconference to announce their initial findings as part of the “draft interim report” so that President Trump can take immediate action on some of the commission’s more pressing recommendations ahead of their final report in October.

Though Christie mentioned that the commission received and reviewed comments from over 8,000 members of the public, not one mention was made of medical marijuana or its potential benefit in the suppression of pain associated with withdrawal symptoms. Christie spoke at length about finding non-addictive alternatives to opioid painkillers, but never discussed what is arguably the most effective alternative to harmful pharmaceuticals in the world today.

The commission’s initial report included…

Continue reading at

About is the leading cannabis-related message forum and news site for in-depth, comprehensive cannabis strain and product education, marijuana media, growshop information and pricing. has been in operation since 1995 and is owned and operated by, the most widely used medical and recreational marijuana dispensary locator in the industry.

Leave a Reply

Your email address will not be published. Required fields are marked *